🔗 Share this article

Chancellor Reeves has revealed she is preparing "focused steps to tackle household expense pressures" in the forthcoming financial statement.

In comments to media outlets, she emphasized that curbing price rises is a shared task of both the administration and the central bank.

The UK's price growth is projected to be the highest among the Group of Seven industrialized countries this year and the following year.

Possible Utility Cost Interventions

It is understood the government could intervene to bring down energy bills, such as by slashing the current 5% level of VAT applied on energy supplies.

A further approach is to cut some of the regulatory levies presently included in bills.

Budgetary Constraints and Expert Expectations

The administration will obtain the next report from the official forecaster, the OBR, on the start of the week, which will clarify how much space there is for such actions.

The consensus from most analysts is that Reeves will have to introduce tax rises or spending cuts in order to meet her voluntary debt limits.

Earlier on the same day, calculations showed there was a twenty-two billion pound shortfall for the chancellor to fill, which is at the more modest range of forecasts.

"It is a collective responsibility between the central bank and the government to continue tackling some of the causes of price increases," Reeves informed the BBC in Washington, at the conferences of the International Monetary Fund and World Bank.

Revenue Pledges and Global Concerns

While much of the focus has been on expected tax increases, the Treasury chief said the latest figures from the fiscal watchdog had not altered her commitment to manifesto promises not to increase tax levels on earnings tax, sales tax or National Insurance.

She attributed an "unpredictable global environment" with increasing international and trade issues for the Budget revenue measures, likely to be directed on those "with the broadest shoulders."

Global Economic Tensions

Addressing worries about the UK's trade ties with the Asian nation she said: "Our national security invariably are paramount."

Last week's declaration by Chinese authorities to strengthen trade restrictions on rare earths and other resources that are essential for advanced tech production led American leader the US President to threaten an extra 100% import tax on goods from the Asian country, raising the prospect of an all-out trade war between the two global powers.

The US Treasury Secretary called China's decision "commercial pressure" and "a international production control attempt."

Asked about accepting the American proposal to participate in its conflict with China, Reeves said she was "extremely troubled" by China's actions and encouraged the Chinese government "to avoid restrictions and limit trade."

She said the decision was "bad for the international commerce and causes additional challenges."

"In my view there are areas where we must challenge Chinese policies, but there are also valuable chances to export to Chinese markets, including financial services and other areas of the economy. We've got to achieve that balance right."

The chancellor also stated she was collaborating with other major economies "on our own critical minerals plan, so that we are reduced dependence."

Health Service Medicine Pricing and Funding

The Chancellor also recognized that the price the National Health Service pays for medicines could increase as a consequence of current talks with the US government and its drugs companies, in exchange for lower tariffs and investment.

Some of the biggest global pharmaceutical manufacturers have said in recent statements that they are either halting or scrapping projects in the UK, with several attributing the modest returns they are obtaining.

Recently, the Science Minister said the price the health service pays for medicines would have to increase to prevent companies and pharmaceutical investment leaving the UK.

Reeves informed the BBC: "It has been observed due to the pricing regime, that drug testing, new drugs have not been offered in the United Kingdom in the manner that they are in other EU nations."

"We want to make sure that people getting care from the NHS are able to access the best essential medicines in the globe. And so we are examining all of that, and... seeking to attract more investment into Britain."